Mobocertinib
Back to searchMolecule Structure
Scientific Name
Mobocertinib
Description of the Drug
Mobocertinib is an oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB16390
http://www.drugbank.ca/drugs/DB16390
Brand Name(s)
Not Available
Company Owner(s)
Takeda Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Epidermal growth factor receptor erbB1 | SINGLE PROTEIN | INHIBITOR | CHEMBL203 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL17373133 |
| PharmGKB | PA166268804 |
| Human Metabolome Database | HMDB0304841 |
| DrugBank | DB16390 |
| PubChem | 118607832 |
| BindingDB | 368374 |
| ChemicalBook | CB74676602 |
| Guide to Pharmacology | 10468 |
